Evidence map›Paper›PMID 36139932›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Distribution and Genomic Characterization of Third-Generation Cephalosporin-Resistant

Yin-Chih Feng, Ci-Hong Liou, Wailap Victor Ng, Feng-Jui Chen, Chih-Hsin Hung, Po-Yen Liu, Yu-Chieh Liao, Han-Chieh Wu, Ming-Fang Cheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yin-Chih FengDepartment of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung 813414, Taiwan.
Ci-Hong LiouNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Hsinchu 35053, Taiwan.
Wailap Victor NgDepartment of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.
Feng-Jui ChenNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Hsinchu 35053, Taiwan.
Chih-Hsin HungInstitute of Biotechnology and Chemical Engineering, I-Shou University, Kaohsiung 84001, Taiwan.
Po-Yen LiuDepartment of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung 813414, Taiwan.
Yu-Chieh LiaoInstitute of Population Health Sciences, National Health Research Institutes, Miaoli 35053, Taiwan.ORCID 0000-0002-4360-7932
Han-Chieh WuNational Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Hsinchu 35053, Taiwan.ORCID 0000-0003-2638-7883
Ming-Fang ChengDepartment of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung 813414, Taiwan.

Funding

Kaohsiung Veterans General Hospital KSVGH111-G01-1, KSVGH111-G01-2, KSVGH111-100, KSVGH111-012, and KSVGH111-013Ministry of Science and Technology of the Republic of China MOST 108-2314-B-075B-002-MY3； MOST111-2314-B-075B-007-MY3Veterans Affairs Council VAC111-005
6 · The paper itself

Abstract

Third-generation cephalosporin-resistant

Indexed as

AmpC β-lactamasesCMY-2Escherichia coliextended-spectrum β-lactamasesplasmidthird-generation cephalosporin-resistant Escherichia coliwhole-genome sequencing

Identifiers

PMID36139932
PMCPMC9495048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.